AAAAAA

   
Results: 1-11 |
Results: 11
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: MISMETTI P LAPORTESIMITSIDIS S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H BONEU B
Citation: P. Mismetti et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 79(6), 1998, pp. 1162-1165
COMPARISON OF A ONCE-DAILY WITH A TWICE-DAILY SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN REGIMEN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS
Authors: CHARBONNIER BA FIESSINGER JN BANGA JD WENZEL E DAZEMAR P SAGNARD L
Citation: Ba. Charbonnier et al., COMPARISON OF A ONCE-DAILY WITH A TWICE-DAILY SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN REGIMEN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 79(5), 1998, pp. 897-901
PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., PHARMACODYNAMICS AND TOLERANCE OF 2 NADROPARIN FORMULATIONS (10,250 AND 20,500 ANTI XA IU-ML(-1)) DELIVERED FOR 10 DAYS AT THERAPEUTIC DOSE, Thrombosis and haemostasis, 79(2), 1998, pp. 338-341
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: BONEU B MISMETTI P LAPORTE S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H
Citation: B. Boneu et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 1997, pp. 1149-1149
COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS
Authors: BONEU B NAVARRO C CAMBUS JP CAPLAIN H DAZEMAR P NECCIARI J DURET JP GAUD C SIE P
Citation: B. Boneu et al., COMPARISON OF THE BIOAVAILABILITY OF 2 NADROPARIN FORMULATIONS (10000AND 20000 ANTI-XA IU.ML-1) IN HEALTHY-YOUNG VOLUNTEERS, Thrombosis and haemostasis, 1997, pp. 1160-1160
COMPARISON OF A ONCE-DAILY WITH A TWICE-DAILY SUBCUTANEOUS NADROPARINCALCIUM REGIMEN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS - THE FRAXODI STUDY
Authors: FLESSINGER JN CHARBONNIER BA SIXMA JJ WENZEL E DAZEMAR P SAGNARD L
Citation: Jn. Flessinger et al., COMPARISON OF A ONCE-DAILY WITH A TWICE-DAILY SUBCUTANEOUS NADROPARINCALCIUM REGIMEN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS - THE FRAXODI STUDY, Thrombosis and haemostasis, 1997, pp. 1582-1582
EFFECT OF NADROPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, ON CLINICAL ANDANGIOGRAPHIC RESTENOSIS AFTER CORONARY BALLOON ANGIOPLASTY - THE FACTSTUDY
Authors: LABLANCHE JM MCFADDEN EP MENEVEAU N LUSSON JR BERTRAND B METZGER JP LEGRAND V GROLLIER G MACAYA C DEBRUYNE B VAHANIAN A GRENTZINGER A MASQUET C WOLF JE TOBELEM G FONTECAVE S VACHERON A DAZEMAR P BERTRAND ME
Citation: Jm. Lablanche et al., EFFECT OF NADROPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN, ON CLINICAL ANDANGIOGRAPHIC RESTENOSIS AFTER CORONARY BALLOON ANGIOPLASTY - THE FACTSTUDY, Circulation, 96(10), 1997, pp. 3396-3402
LOW-MOLECULAR-WEIGHT HEPARIN AND COMPRESSION STOCKINGS IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN NEUROSURGERY
Authors: NURMOHAMED MT VANRIEL CMA HENKENS CMA KOOPMAN MMW QUE GTH DAZEMAR P BULLER HR TENCATE JW HOEK JA VANDERMEER J VANDERHEUL C TURPIE AGG HALEY S SICURELLA M
Citation: Mt. Nurmohamed et al., LOW-MOLECULAR-WEIGHT HEPARIN AND COMPRESSION STOCKINGS IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN NEUROSURGERY, Thrombosis and haemostasis, 75(2), 1996, pp. 233-238
TREATMENT OF VENOUS THROMBOSIS WITH INTRAVENOUS UNFRACTIONATED HEPARIN ADMINISTERED IN THE HOSPITAL AS COMPARED WITH SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED AT HOME
Authors: KOOPMAN MMW PRANDONI P PIOVELLA F OCKELFORD PA BRANDJES DPM VANDERMEER J GALLUS AS SIMONNEAU G CHESTERMAN CH PRINS MH BOSSUYT PMM DEHAES H VANDENBELT AGM SAGNARD L DAZEMAR P BULLER HR
Citation: Mmw. Koopman et al., TREATMENT OF VENOUS THROMBOSIS WITH INTRAVENOUS UNFRACTIONATED HEPARIN ADMINISTERED IN THE HOSPITAL AS COMPARED WITH SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED AT HOME, The New England journal of medicine, 334(11), 1996, pp. 682-687
COMPARISON OF A ONCE-DAILY VERSUS A TWICE-DAILY SUBCUTANEOUS NADROPARIN CALCIUM REGIMENS IN THE TREATMENT OF DEEP-VEIN THROMBOSIS - ON BEHALF OF THE FRAXODI GROUP
Authors: CHARBONNIER BA FIESSINGER JN SIXMA JJ WENZEL E DAZEMAR P SAGNARD L
Citation: Ba. Charbonnier et al., COMPARISON OF A ONCE-DAILY VERSUS A TWICE-DAILY SUBCUTANEOUS NADROPARIN CALCIUM REGIMENS IN THE TREATMENT OF DEEP-VEIN THROMBOSIS - ON BEHALF OF THE FRAXODI GROUP, Circulation, 94(8), 1996, pp. 4343-4343
LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND COMPRESSION STOCKINGS IN THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) IN NEUROSURGERY
Authors: NURMOHAMED MT VANRIEL AM HENKENS CMA KOOPMAN MMW QUE GTH DAZEMAR P BULLER HR TENCATE JW HOEK JA VANDERMEER J VANDERHEUL C TURPIE AGG HALEY S SICURELLA J GENT M
Citation: Mt. Nurmohamed et al., LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND COMPRESSION STOCKINGS IN THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) IN NEUROSURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 973-973
Risultati: 1-11 |